Citation: Ah. Tinmouth et al., Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis, ANN PHARMAC, 35(6), 2001, pp. 669-674
Citation: Mj. Kovacs et Am. Teefy, Comment: other factors should be considered in a possible warfarin and sulfasalazine interaction - Authors' reply, ANN PHARMAC, 35(4), 2001, pp. 506-506
Citation: Ds. Allan et al., Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy, HAEMATOLOG, 86(8), 2001, pp. 844-850
Authors:
Kovacs, MJ
MacKinnon, KM
Anderson, D
O'Rourke, K
Keeney, M
Kearon, C
Ginsberg, J
Wells, PS
Citation: Mj. Kovacs et al., A comparison of three rapid D-dimer methods for the diagnosis of venous thromboembolism, BR J HAEM, 115(1), 2001, pp. 140-144
Authors:
Wells, PS
Anderson, DR
Rodger, M
Stiell, I
Dreyer, JF
Barnes, D
Forgie, M
Kovacs, G
Ward, J
Kovacs, MJ
Citation: Ps. Wells et al., Excluding pulmonary embolism at the bedside without diagnostic imaging: Management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer, ANN INT MED, 135(2), 2001, pp. 98-107
Citation: C. Luk et al., Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy, AM J MED, 111(4), 2001, pp. 270-273
Authors:
English, KE
Brien, WF
Howson-Jan, K
Kovacs, MJ
Citation: Ke. English et al., Acquired factor VIII inhibitor in a patient with chronic myelogenous leukemia receiving interferon-alfa therapy, ANN PHARMAC, 34(6), 2000, pp. 737-739
Citation: S. Maharaj et al., Successful anticoagulation with dalteparin in a patient with mechanical heart valves, ANN PHARMAC, 33(11), 1999, pp. 1188-1191
Citation: Dl. Bauld et Mj. Kovacs, Dalteparin in emergency patients to prevent admission prior to investigation for venous thromboembolism, AM J EMER M, 17(1), 1999, pp. 11-14
Authors:
Savage, KJ
Wells, PS
Schulz, V
Goudie, D
Morrow, B
Cruickshank, M
Kovacs, MJ
Citation: Kj. Savage et al., Outpatient use of low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis of the upper extremity, THROMB HAEM, 82(3), 1999, pp. 1008-1010
Authors:
Kovacs, MJ
Keeney, M
MacKinnon, K
Boyle, E
Citation: Mj. Kovacs et al., Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparin, CLIN LAB H, 21(1), 1999, pp. 55-60
Authors:
Kearon, C
Gent, M
Hirsh, J
Weitz, J
Kovacs, MJ
Anderson, DR
Turpie, AG
Green, D
Ginsberg, JS
Wells, P
MacKinnon, B
Julian, JA
Citation: C. Kearon et al., A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism, N ENG J MED, 340(12), 1999, pp. 901-907
Authors:
Kovacs, MJ
Cruickshank, M
Wells, PS
Kim, H
Chin-Yee, I
Morrow, B
Boyle, E
Kovacs, J
Citation: Mj. Kovacs et al., Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease, HAEMOSTASIS, 28(2), 1998, pp. 62-69